Alzheimer’s drugs keep failing, but why?

Last November, Eli Lilly abandoned its leading Alzheimer’s drug after recent failures during clinical trials. It’s not that the drug didn’t fulfill its mission of clearing out plaques in the brain; the problem was that plaques were removed but patients experienced no...

21st Century Cures Act deadlines approaching

The 21st Century Cures Act passed with resounding bipartisan support in the final days of President Barack Obama’s second term. The bill, which includes initiatives impacting several federal organizations and the clinical research ecosystem, will be implemented over...